Management of drug allergy-clinical update

Management of drug allergy-clinical update

The new classification of drug hypersensitivity reactions (DHRs) is based on phenotypes, endotypes, and biomarkers. Immediate and delayed reactions are the clinical phenotypic presentation while endotypes are based on cellular, biological mediators, and biomarkers. Complement activation, cyclooxygen...

Full description

Bibliographic Details
Main Authors:	P C Kathuria, Manisha Rai
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2022-01-01
Series:	Indian Journal of Allergy Asthma and Immunology
Subjects:	acute generalized exanthematous pustulosis adverse drug reaction desensitization models desensitization drug allergy drug hypersensitivity reaction drug rash with eosinophilia and systemic symptoms high-affinity immunoglobulin e fcε receptor i immunoglobulin e scar stevens-johnson syndrome toxic epidermal necroplasia
Online Access:	http://www.ijaai.in/article.asp?issn=0972-6691;year=2022;volume=36;issue=1;spage=4;epage=17;aulast=Kathuria

Similar Items

Severe cutaneous adverse reactions in a tertiary care center in JamaicaCapsule Summary
by: Alicia J.S. McNish, BMedSc, MBBS, DM, et al.
Published: (2024-06-01)

Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies
by: Chen CB, et al.
Published: (2018-05-01)

Analysis of severe cutaneous adverse reactions (SCARs) in Taiwan drug-injury relief system: 18-year results
by: Po-Wei Huang, et al.
Published: (2022-08-01)

Hypersensitivity to Intravenous Iron Preparations
by: Silvia Caimmi, et al.
Published: (2022-09-01)

Hypersensitivity Reactions to Monoclonal Antibodies in Children
by: Francesca Mori, et al.
Published: (2020-05-01)

Successful Desensitization to Sorafenib and Imatinib—A Report of Two Cases and a Literature Review
by: Natasa Kusic, et al.
Published: (2024-03-01)

Tolerated drugs in subjects with severe cutaneous adverse reactions (SCARs) induced by anticonvulsants and review of the literature
by: Fabrizio De Luca, et al.
Published: (2017-10-01)

A novel outpatient desensitization protocol for recombinant human erythropoietin allergy in a pediatric patient
by: Jaime S. Rosa, et al.
Published: (2018-03-01)

How to Prevent and Mitigate Hypersensitivity Reactions to Biologicals Induced by Anti-Drug Antibodies?
by: Alessandra Vultaggio, et al.
Published: (2021-11-01)

Rapid drug desensitization with platin-based chemotherapy: Analysis of risk factors for breakthrough reactions
by: Begum Gorgulu Akin, MD, et al.
Published: (2022-01-01)

Stevens–Johnson syndrome and toxic epidermal necrolysis: A fresh look at an old foe
by: Sowmya Kaimal, et al.
Published: (2023-01-01)

Hypersensitivity reactions with first-line antituberculosis drugs and outcomes of rapid desensitizations
by: Gozde Koycu Buhari, MD, et al.
Published: (2024-01-01)

Long-term outcome of patients with severe cutaneous adverse reactions
by: Yoko Kano, et al.
Published: (2013-12-01)

PHENYTION, CARBAMAZEPINE, SODIUM VALPROATE AND LAMOTRIGINE INDUCED CUTANEOUS REACTIONS
by: M. Ghaffarpour, et al.
Published: (2005-04-01)

PHENYTION, CARBAMAZEPINE, SODIUM VALPROATE AND LAMOTRIGINE INDUCED CUTANEOUS REACTIONS
by: M. Ghaffarpour, et al.
Published: (2005-02-01)

Acute generalized exanthematous pustulosis induced by sulfasalazine: Uncommon presentation of a common culprit
by: Deepak Vashisht, et al.
Published: (2022-01-01)

Acute generalized exanthematous pustulosis simulating Stevens-Johnson syndrome/toxic epidermal necrolysis associated with the use of vismodegib
by: Oscar M. Moreno-Arrones, MD, et al.
Published: (2018-03-01)

Acute Localized Exanthematous Pustulosis (ALEP) Caused by Topical Application of Minoxidil
by: Michael Makris, et al.
Published: (2023-01-01)

Insulin Allergy
by: Füsun Erdenen, et al.
Published: (2016-09-01)

Use of Rapid Drug Desensitization in Delayed Hypersensitivity Reactions to Chemotherapy and Monoclonal Antibodies
by: Arantza Vega, et al.
Published: (2022-01-01)

Association between HLA alleles and beta-lactam antibiotics-related severe cutaneous adverse reactions
by: Pansakon Wattanachai, et al.
Published: (2023-09-01)

Spectrum of severe cutaneous adverse drug reactions among pediatric population and management options
by: Sameer Abrol, et al.
Published: (2022-01-01)

Delayed Drug Hypersensitivity Reactions: Molecular Recognition, Genetic Susceptibility, and Immune Mediators
by: Mu-Tzu Chu, et al.
Published: (2023-01-01)

Analysis of Breakthrough Reactions in 1,143 Desensitization Procedures in a Single Tertiary Hospital Using a One-Bag Desensitization Protocol
by: Hyun Hwa Kim, et al.
Published: (2022-02-01)

Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugs
by: Chih-Hsuan Wung, et al.
Published: (2023-04-01)

The first successful desensitization protocol in exenatide allergy: a case report
by: Osman Ozan Yeğit, et al.
Published: (2023-01-01)

Naltrexone-induced acute generalized exanthematous pustulosis
by: Jason Eakes, BS, et al.
Published: (2023-09-01)

Acute Generalized Exanthematous Pustulosis Due to Cephalexin: A Case Report and Literature Review
by: Shirin Sheibani, et al.
Published: (2021-07-01)

A Case of Toxic Epidermal Necrolysis Successfully Treated with Low Dose Intravenous Immunoglobulins and Systemic Corticosteroid
by: Lutfi Al-Kathiri, et al.
Published: (2018-07-01)

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Patients Admitted to Sina Hospital in Hamadan, Iran: A 16-year study
by: Pedram Alirezaei, et al.
Published: (2019-03-01)

Same-Day Desensitization in Patients Who Experience Their First Reaction to a Platin Agent at the Oncology Day Unit: A Pilot Study to Safely Include This Technique Within the Multidisciplinary Pathways for the Diagnosis & Management of Hypersensitivity to Platin Agents
by: Julián Borrás Cuartero, et al.
Published: (2022-06-01)

Collaboration in pharmacovigilance: lamotrigine and fatal severe cutaneous adverse reactions – a review of spontaneous reports
by: Brickel N, et al.
Published: (2017-07-01)

FcεRI: A Master Regulator of Mast Cell Functions
by: Yuka Nagata, et al.
Published: (2022-02-01)

DRUG-INDUCED STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS
by: Dalia Dop, et al.
Published: (2016-12-01)

High Grade Dermatologic Adverse Events Associated With Immune Checkpoint Blockade for Cancer
by: Alyce M. Kuo, et al.
Published: (2022-06-01)

Intravenous immunoglobulin in the treatment of drug rash eosinophilia and systemic symptoms caused by phenytoin
by: Ponnusamy Santhamoorthy, et al.
Published: (2012-01-01)

DENTAL CARE LEVEL ASSESSMENT AT SDS/TEN: SYSTEMATIC ANALYSIS OF CLINICAL CASES
by: S.V. Kolomiiets, et al.
Published: (2019-09-01)

Acute localized exanthematous pustulosis of the leg: A case report
by: Wen Shuo Tiong, et al.
Published: (2023-12-01)

Allergic Reaction due to Anti-Tuberculosis Drugs, How to Manage?
by: Nur Prasetyo Nugroho, et al.
Published: (2021-05-01)

Severe cutaneous reactions to drugs in the setting of a general hospital
by: Luciana Rosa Grando, et al.
Published: (2014-09-01)